Accelerating Antibody Discovery for Complex Targets: Digital Platforms & AI Integration for GPCRs
9:30 am - Tuesday 28th April 2026
- Digitalization and optimization of biotherapeutics discovery workflows accelerate identification of antibodies against challenging targets such as GPCRs
- Automated platforms leveraging integrated sequence, screening, and informatics datanenable efficient selection from large, diverse antibody panels
- These advancements provide a foundation for AI/ML applications to address complex therapeutic targets such as GPCRs
